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ABSTRACT 
Consumption of probiotics has been associated with decreased risk of colon cancer and 
reported to have antimutagenic/ anti-carcinogenic properties. One possible mechanism for 
this effect involves physical binding of the mutagenic compounds, such as heterocyclic 
amines (HCAs), to the bacteria. Therefore, the objective of this study was to examine the 
binding capacity of bifidobacterial strains of human origin on mutagenic heterocyclic amines 
which are suspected to play a role in human cancers. In vitro binding of the mutagens Trp-p-
2, IQ, MeIQx, 7,8DiMeIQx and PhIP by three bacterial strains in two media of different pH 
was analysed using high performance liquid chromatography. Bifidobacterium 
pseudocatenulatum G4 showed the highest decrease in the total HCAs content, followed by 
Bifidobacterium longum, and Escherichia coli. pH affects binding capacity; the highest 
binding was obtained at pH 6.8. Gram-positive tested strains were found to be consistently 
more effective than the gram-negative strain. There were significant decreases in the amount 
of HCAs in the presence of different cell concentrations of B. pseudocatenulatum G4; the 
highest decrease was detected at the concentration of 10(10) cfu/ml. The results showed that 
HCAs were able to bind with all bacterial strains tested in vitro, thus it may be possible to 
decrease their absorption by human intestine and increase their elimination via faeces. 
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